111In-DOTA-Lanreotide Scintigraphy in Patients with Tumors of the Lung
Tatjana Traub,
Ventzislav Petkov,
Sedat Ofluoglu,
Thomas Pangerl,
Markus Raderer,
Barbara J. Fueger,
Wolfgang Schima,
Amir Kurtaran,
Robert Dudczak and
Irene Virgolini
Departments of Nuclear Medicine, Pulmonology, Oncology, and Radiology and Ludwig Boltzmann Institute of Nuclear Medicine, University of Vienna, Vienna; and Nuclear Medicine Institute, Hospital Lainz, Vienna, Austria

View larger version (80K):
[in a new window]
|
FIGURE 1. Coronal (A), sagittal (B), and axial (C) views of 111In-DOTA-LAN SPECT study of patient with squamous cell carcinoma of left lung. (D) Corresponding CT study.
|
|

View larger version (19K):
[in a new window]
|
FIGURE 2. 111In-DOTA-LAN specific binding to squamous cell carcinoma. Inset shows 2 high-affinity binding classes: Kd values of 0.5 and 5 nmol/L.
|
|

View larger version (45K):
[in a new window]
|
FIGURE 3. Northern blot analysis (patient 3, Table 4). Transfected and nontransfected COS7 cells were used as positive and negative controls, respectively.
|
|
Copyright © 2001 by the Society of Nuclear Medicine.